Second Sight Medical Products, Inc. Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants (EYESW) Expiration Date
January 07, 2019 08:05 ET
|
Second Sight Medical Products, Inc.
LOS ANGELES, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual...
Second Sight Reports Fourth Quarter 2018 Business Update
January 07, 2019 08:00 ET
|
Second Sight Medical Products, Inc.
-- Full Year 2018 net revenue estimated to be in the range of $6.5-$6.9 million -- -- 6th Orion patient scheduled for implantation at Baylor Medical Center -- LOS ANGELES, Jan. 07, 2019 (GLOBE...
Second Sight to Present at Digital Medicine and Medtech Showcase 2019
December 20, 2018 08:00 ET
|
Second Sight Medical Products, Inc.
LOS ANGELES, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual...
Second Sight Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
December 14, 2018 08:00 ET
|
Second Sight Medical Products, Inc.
LOS ANGELES, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual...
Second Sight to Present at the 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th
November 27, 2018 16:30 ET
|
Second Sight Medical Products, Inc.
LOS ANGELES, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual...
Second Sight Reports Third Quarter 2018 Financial Results
November 07, 2018 16:01 ET
|
Second Sight Medical Products, Inc.
Encouraging Interim Results of Orion® Feasibility Study with Four Subjects Cleared for Home Use LOS ANGELES, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (NASDAQ: EYES)...
Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System
November 06, 2018 16:01 ET
|
Second Sight Medical Products, Inc.
LOS ANGELES, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual...